PEOPLE - Gambro makes promotion:
This article was originally published in Clinica
Executive Summary
Gambro's UK subsidiary Gambro Hospal (Huntingdon, Hertfordshire) has promoted sales and marketing director David Coorey as managing director. Australian by birth, Mr Coorey moved to the UK in 1992 and embarked on a career in sales with Fresenius, initially covering renal disease products, and thereafter joined Fresenius Kabi to promote enteral nutrition products. He later became business manager for the IV therapy and homecare division, and in 2003, joined Gambro Hospal.
You may also be interested in...
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.
Roche Gets Adjuvant ALK+ Lung Cancer To Itself With Alecensa Approval
The US FDA cleared Roche’s supplemental approval request for ALK inhibitor Alecensa in ALK-positive non-small cell lung cancer following tumor resection.